Glucose-induced insulin secretion from islets cultured in the presence of interleukin-6 (IL-6) for 12-24 h was inhibited to a similar extent as when islets were treated with interleukin-l (IL-I1,). However, unlike IL-i,/, IL-6 did not potentiate insulin secretion during an acute (30 min) exposure of islets to the cytokine, nor did it inhibit DNA synthesis during a 24 h culture period. A 12 h pretreatment of islets with tumour necrosis factor-a (TNF-a) combined with IL-i1 potentiated the inhibitory effect of IL-1,8 on secretion, such that 20 mM-glucose-induced insulin secretion was abolished. No synergistic inhibition of secretion was observed with TNF-a and IL-6. However, IL-1,6 and IL-6 were found to inhibit insulin secretion in an additive manner. These results suggest that IL-6 inhibits insulin secretion in a manner distinct from that of IL-146, and that IL-6 is unlikely to mediate the inhibitory effects of IL-1i, or TNF-a on rat islets of Langerhans.
INTRODUCTION
It has been suggested that cytokines released from activated macrophages during the process of insulitis may contribute to the destruction of the islet f-cell in insulin-dependent diabetes mellitus (IDDM) . The report of raised serum levels of interleukin-l, (IL-1,/) and tumour necrosis factor-a (TNF-a) in recently diagnosed IDDM patients (Hussain et al., 1990) further supports an involvement of these cytokines in the development of this autoimmune disease. Acute exposure (< lh) of islets to IL-,fl potentiates glucose-induced insulin secretion, whereas a more prolonged exposure results in the inhibition of insulin secretion and DNA synthesis, decreased glucose oxidation, and ultimately cell death (for review see McDaniel et al., 1988) . Another macrophage-derived product, TNF-a, has been shown to synergize with 8 to potentiate the inhibition of insulin secretion and give rise to islet cell lysis (Pukel et al., 1988) . Specific plasma membrane receptors for IL-if, have been demonstrated on numerous cell types (see Dower & Urdal, 1987) , and more recently on an insulin-secreting fl-cell line (Hammonds et al., 1990) . Thus IL-if1 may act directly upon the islet fl-cell. Individually, IL-1,6 and TNF-a induce the secretion of the cytokine interleukin-6 (IL-6) from a variety of cell types including macrophages, fibroblasts and endothelial cells (Wong & Clark, 1988) , and, moreover, IL-if1 and TNF-a stimulate fibroblast IL-6 production in a synergistic manner (Elias & Lentz, 1990) . Pancreatic islet fl-cells may also produce IL-6 (Campbell et al., 1989) . Thus IL-6 has been considered as a potential mediator of the effects of IL-Ifi. In this study we investigate the effects of IL-6 on insulin secretion and DNA synthesis in cultured rat islets of Langerhans to determine whether IL-6 is a likely mediator of the effects of IL-1,if. We also examine the interactions of IL-6, IL-I,f and TNF-a on cultured rat islets of Langerhans to assess the potential contribution of these cytokines to the development of impaired islet fl-cell function in IDDM.
MATERIALS AND METHODS Cytokines
Recombinant human cytokines were from NIBSC: IL-,4i (code 86/526B), IL-6 (unglycosylated) (code 87/736) and TNFa (code 87/630).
Islet isolation and tissue culture
Islets of Langerhans were isolated from groups of four female Sprague-Dawley rats (180-200 g) by a collagenase digestion technique (Howell & Taylor, 1968) . Islets were separated from pancreatic acinar tissue by centrifugation (800 g, 5 min) in 23 % (w/v) Dextran T70 (Pharmacia) in a bicarbonate-buffered medium (Gey & Gey, 1936) , and collected using a finely drawn out Pasteur pipette. Islets were precultured for a period of 48 h in RPMI-1640 medium supplemented with penicillin (60000 units/ litre), streptomycin (100 mg/l) and 5 % foetal calf serum (Gibco) prior to all studies.
Insulin secretion studies
To determine the acute effects of cytokine treatment, islets were removed from tissue culture and preincubated in medium (Gey & Gey, 1936) containing 2 mM-glucose for 1 h at 37 'C. Groups of five islets were then incubated for 30 min in medium containing 8 mM-glucose in the presence or the absence of cytokines (10 pM-1 nM). Insulin secreted into the medium was measured by radioimmunoassay (Green et al., 1983) .
To determine the effect of prolonged cytokine treatment, islets were cultured for a further 6, 12 or 24 h in the presence or the absence of cytokines. Islets were rinsed and preincubated for 1 h in medium containing 2 mM-glucose. Groups of three islets were then incubated for 30 min in medium containing 2 mm-or 20 mM-glucose. Insulin secretion and total islet insulin contents (extracted in ethanol/water/conc. HCI; 50:15:1, by vol., for 24 h at 4°C) were determined as above.
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C. Southern, D. Schulster and I. C. Green Islet DNA content and DNA synthesis Groups of 30 islets, cultured for 24 h in the presence of 0.5 nm cytokines in medium supplemented with 2 ,uCi of [3H]-thymidine/ml (Amersham) were washed extensively and sonicated in 500 ul of distilled water. Portions of 100 l1 were mixed with 500 ,1 of 5 % trichloroacetic acid, and [3Hlthymidine incorporation was determined as previously described (Swenne, 1990) . Total islet DNA was determined in 50 #l1 samples of the islet sonicate (Green & Taylor, 1972) .
Statistics
Results were analysed using an unpaired Student's t test.
RESULTS
Insulin secretion studies IL-If (0.1-1 nm) potentiated 8 mm-glucose-induced insulin secretion from islets exposed to the cytokine during a 30 min incubation, but IL-6 over the same concentration range did not affect insulin secretion (Table 1) . However, the treatment of islets for 24 h with IL-6 resulted in a dose-dependent inhibition of insulin secretion in response to a subsequent 20 mm-glucose challenge (Table 2 ). IL-6 gave a similar degree of inhibition of insulin secretion as that produced by IL-1,8 at a concentration of 1 nm, and both IL-I1 and IL-6 significantly raised basal insulin Table 1 . Effects of short-tenn IL treatment on insulin secretion release in the presence of 2 mm-glucose (Table 2 ). An inhibitory effect of IL-i1, (0.5 nim), but not of IL-6 (0.5 nM), on 20 mmglucose-induced insulin secretion was observed as early as after 6 h of exposure to the cytokine (35.1 + 4.2 and 88.6 + 11.3 versus 71.2+ 12.4 fmol/30 min per islet respectively; P < 0.005, n = 19-24 from two separate experiments). When the exposure period was increased to 12 h, IL-6 (0.5 nm) was found to inhibit insulin secretion to the same degree as IL-1,8 (0.5 nm), and TNF-a (0.5 nm) pretreatment was without effect (Table 3) . Insulin secretion induced by 20 mm-glucose was abolished after a 12 h exposure to the combinations of IL-if? plus IL-6 (0.5 nm), or IL-1,f plus TNF-a (0.5 nM), so that insulin secretion was not significantly different from basal release in the presence of 2 mmglucose (Table 3) . However, when TNF-a was combined with IL-6, the inhibitory effect on insulin secretion was no greater than that observed with IL-6 alone. Basal insulin release in the presence of 2 mm-glucose and total islet insulin contents were not affected by the 12 h cytokine treatments described in Table 3 (results not shown).
Islet DNA and insulin contents and DNA synthesis Total islet DNA and insulin contents were not affected by a 24 h exposure to IL-1If or IL-6 (0.5 nm) ( Cytokines and insulin secretion IL-1, plus IL-6 did not affect the inhibition of DNA synthesis observed with IL-1I, alone (Table 4) .
DISCUSSION
Human recombinant IL-6 inhibited in a dose-dependent manner glucose-induced insulin secretion from cultured rat islets of Langerhans pretreated with the cytokine in vitro. However, acute exposure of islets to IL-6 did not give the potentiation of glucose-induced insulin secretion associated with IL-iI (Spinas et al., 1986) . The similar degree of inhibition obtained with (1 nM), and the raised basal insulin release following a 24 h exposure to these cytokines (Table 2) , are consistent with the hypothesis that IL-6 is a mediator of the long-term inhibitory, and possibly cytotoxic, effects of IL-1/? on islet f-cell function. However, at the time points studied here, no cell death was indicated, as islet DNA and insulin contents were not affected. A cytotoxic effect of IL-6 on islets has previously been suggested (Buschard et al., 1989; Sandler et al., 1990) . Islets exposed to IL-6 for 48 h showed raised levels of insulin in the culture medium but had a decreased secretory response to a subsequent glucose challenge, with a small but significant decrease in islet DNA content (Sandler et al., 1990) . Ultrastructural abnormalities similar to those observed in IL-/lI-treated islets have been described in islets exposed to IL-6 (Buschard et al., 1989) . We found that IL-6, unlike IL-1,f, did not lower the incorporation of
[3H]thymidine into DNA, nor did it alter the effect of IL-Ia on DNA synthesis when these cytokines were used in combination, suggesting that IL-6 is not a mediator for the cytotoxic effect of IL-i/ on islet DNA synthesis. Further differences in the actions of IL-I1, and IL-6 on insulin secretion were also observed. Inhibition of secretion after pretreatment with IL-I1, (6 h) was more rapid than with IL-6 (12 h); moreover, the combination of IL-6 plus IL-1,i (12 h) was found to inhibit insulin secretion in an additive manner, in contrast with the report that IL-6 preserves the secretory response from islets co-cultured with an inhibitory dose of IL-1i6 (Buschard et al., 1989) . Thus our results support the existence of distinct modes of action of IL-6 and IL-1i on the islet f-cell, which is in agreement with the findings that a major effect of IL-lfl on the islet fl-cell is to decrease glucose oxidation and oxygen uptake (Sandler et al., 1987) , whereas IL-6 increases both of these parameters (Sandler et al., 1990) . We further differentiated between the actions of IL-6 and IL-1i, by pretreating islets with these cytokines in combination with TNF-az.
Although a synergistic inhibitory effect of IL-i1, and TNF-a on insulin secretion was clearly demonstrated, synergism between IL-6 and TNF-a was not observed. In conclusion, prolonged exposure of rat islets of Langerhans to IL-6 results in the inhibition of glucose-induced insulin secretion, the effect of which is more pronounced in the presence of IL-IlI. However, from the differences in the actions of IL-6 and IL-1,i described here, IL-6 is unlikely to mediate the actions of IL-1,i on islet function. Thus IL-6, along with IL-1,8 and TNF-a, when released in the vicinity of the islet fl-cell as a consequence of an autoimmune process, may contribute to the impaired fl-cell function characteristic of the early stages of IDDM.
